Concepedia

Christopher L. Lynch

CL

Statistics

Publications

17

Citations

2.6K

H-Index

15

Active since

1995

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

University of Wisconsin–Madison

The University of Texas at Austin

Christopher L. Lynch is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, pharmacology, and ligand binding.

Publications per year

1995–2007

17

Publications

17

Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists

Suzanne Mandala, Richard Hajdu, James D. Bergstrom et al. · Science · 2002 · 1.7K citations

, , +17

Potent 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists: effects of fused heterocycles on antiviral activity and pharmacokinetic properties

Dooseop Kim, Liping Wang, Jeffrey J. Hale et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 149 citations · Full text

, , +16

Discovery and Design of Novel HSP90 Inhibitors Using Multiple Fragment‐based Design Strategies

Jeffrey R. Huth, Chang Park, Andrew M. Petros et al. · Chemical Biology & Drug Design · 2007 · 118 citations · Full text

, , +14

Discovery of Potent 3,5-Diphenyl-1,2,4-oxadiazole Sphingosine-1-phosphate-1 (S1P<sub>1</sub>) Receptor Agonists with Exceptional Selectivity against S1P<sub>2</sub> and S1P<sub>3</sub>

Zhen Li, Weirong Chen, Jeffrey J. Hale et al. · Journal of Medicinal Chemistry · 2005 · 99 citations · Full text

, , +10

Applications of Vinylogous Mannich Reactions. Total Syntheses of the <i>Ergot</i> Alkaloids Rugulovasines A and B and Setoclavine

Spiros Liras, Christopher L. Lynch, Andrew M. Fryer et al. · Journal of the American Chemical Society · 2001 · 92 citations

, , +15

1–5 of 17